Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 246
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
More Details on the Psilocybin Mushroom Bluing Reaction
Why Don’t Magic Mushroom Spores Contain Psilocybin?
Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain
Is Nitrous Oxide a Psychedelic Drug?
Psychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin...
Cybin Announces Additional Adelia Milestone Achievements
Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple...
Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at...
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD...
atai Launches Revixia Life Sciences to Develop Salvinorin A for a...
Load more